Cargando…
Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3
Unraveling the noncoding RNA expression networks governing cancer initiation and development is essential while remains largely uncompleted in retroperitoneal liposarcoma (RLS). Through RNA-seq technologies and computational biology, deregulated long noncoding RNAs (lncRNAs) are being identified and...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546787/ https://www.ncbi.nlm.nih.gov/pubmed/31160581 http://dx.doi.org/10.1038/s41419-019-1658-2 |
_version_ | 1783423576944148480 |
---|---|
author | Zhang, Yong Tong, Hanxing He, Junyi Shao, Yebo Guo, Xi Zhuang, Rongyuan Yang, Jue Liu, Ju Ding, Yuqin Liu, Wenshuai Lu, Weiqi Zhou, Yuhong |
author_facet | Zhang, Yong Tong, Hanxing He, Junyi Shao, Yebo Guo, Xi Zhuang, Rongyuan Yang, Jue Liu, Ju Ding, Yuqin Liu, Wenshuai Lu, Weiqi Zhou, Yuhong |
author_sort | Zhang, Yong |
collection | PubMed |
description | Unraveling the noncoding RNA expression networks governing cancer initiation and development is essential while remains largely uncompleted in retroperitoneal liposarcoma (RLS). Through RNA-seq technologies and computational biology, deregulated long noncoding RNAs (lncRNAs) are being identified and reveal that lncRNAs are implicated in serial steps of RLS development. High-throughput sequencing with computational methods for assembling the transcriptome of five paired RLS patient’s tissues. We found that long intergenic noncoding RNA 423 (linc00423) was downregulated in RLS tissues. Gain-of-function assays revealed that overexpressed linc00423 obviously inhibited RLS cell growth in vitro and in vivo. Additionally, RNA sequence, RNA-pulldown and RIP assays evidenced that linc00423 involved in MAPK signaling pathway via destabilizing of nuclear factor of activated T-cells 3 (NFATC3). Summing up, our findings demonstrated that linc00423 acted as the tumor suppressor in RLS cells through regulating the protein level of NFATC3 at a post-transcriptional level and negatively regulated the MAPK signaling pathway at a transcriptional level. Linc00423 might serve as a candidate prognostic biomarker and a target for novel therapies of RLS patients. |
format | Online Article Text |
id | pubmed-6546787 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-65467872019-06-17 Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3 Zhang, Yong Tong, Hanxing He, Junyi Shao, Yebo Guo, Xi Zhuang, Rongyuan Yang, Jue Liu, Ju Ding, Yuqin Liu, Wenshuai Lu, Weiqi Zhou, Yuhong Cell Death Dis Article Unraveling the noncoding RNA expression networks governing cancer initiation and development is essential while remains largely uncompleted in retroperitoneal liposarcoma (RLS). Through RNA-seq technologies and computational biology, deregulated long noncoding RNAs (lncRNAs) are being identified and reveal that lncRNAs are implicated in serial steps of RLS development. High-throughput sequencing with computational methods for assembling the transcriptome of five paired RLS patient’s tissues. We found that long intergenic noncoding RNA 423 (linc00423) was downregulated in RLS tissues. Gain-of-function assays revealed that overexpressed linc00423 obviously inhibited RLS cell growth in vitro and in vivo. Additionally, RNA sequence, RNA-pulldown and RIP assays evidenced that linc00423 involved in MAPK signaling pathway via destabilizing of nuclear factor of activated T-cells 3 (NFATC3). Summing up, our findings demonstrated that linc00423 acted as the tumor suppressor in RLS cells through regulating the protein level of NFATC3 at a post-transcriptional level and negatively regulated the MAPK signaling pathway at a transcriptional level. Linc00423 might serve as a candidate prognostic biomarker and a target for novel therapies of RLS patients. Nature Publishing Group UK 2019-06-03 /pmc/articles/PMC6546787/ /pubmed/31160581 http://dx.doi.org/10.1038/s41419-019-1658-2 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Zhang, Yong Tong, Hanxing He, Junyi Shao, Yebo Guo, Xi Zhuang, Rongyuan Yang, Jue Liu, Ju Ding, Yuqin Liu, Wenshuai Lu, Weiqi Zhou, Yuhong Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3 |
title | Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3 |
title_full | Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3 |
title_fullStr | Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3 |
title_full_unstemmed | Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3 |
title_short | Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3 |
title_sort | linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing mapk signaling pathway through destabilizing of nfatc3 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546787/ https://www.ncbi.nlm.nih.gov/pubmed/31160581 http://dx.doi.org/10.1038/s41419-019-1658-2 |
work_keys_str_mv | AT zhangyong linc00423asatumorsuppressorinretroperitonealliposarcomaviaactivingmapksignalingpathwaythroughdestabilizingofnfatc3 AT tonghanxing linc00423asatumorsuppressorinretroperitonealliposarcomaviaactivingmapksignalingpathwaythroughdestabilizingofnfatc3 AT hejunyi linc00423asatumorsuppressorinretroperitonealliposarcomaviaactivingmapksignalingpathwaythroughdestabilizingofnfatc3 AT shaoyebo linc00423asatumorsuppressorinretroperitonealliposarcomaviaactivingmapksignalingpathwaythroughdestabilizingofnfatc3 AT guoxi linc00423asatumorsuppressorinretroperitonealliposarcomaviaactivingmapksignalingpathwaythroughdestabilizingofnfatc3 AT zhuangrongyuan linc00423asatumorsuppressorinretroperitonealliposarcomaviaactivingmapksignalingpathwaythroughdestabilizingofnfatc3 AT yangjue linc00423asatumorsuppressorinretroperitonealliposarcomaviaactivingmapksignalingpathwaythroughdestabilizingofnfatc3 AT liuju linc00423asatumorsuppressorinretroperitonealliposarcomaviaactivingmapksignalingpathwaythroughdestabilizingofnfatc3 AT dingyuqin linc00423asatumorsuppressorinretroperitonealliposarcomaviaactivingmapksignalingpathwaythroughdestabilizingofnfatc3 AT liuwenshuai linc00423asatumorsuppressorinretroperitonealliposarcomaviaactivingmapksignalingpathwaythroughdestabilizingofnfatc3 AT luweiqi linc00423asatumorsuppressorinretroperitonealliposarcomaviaactivingmapksignalingpathwaythroughdestabilizingofnfatc3 AT zhouyuhong linc00423asatumorsuppressorinretroperitonealliposarcomaviaactivingmapksignalingpathwaythroughdestabilizingofnfatc3 |